(Q24245774)

3

0 references

Anat Gafter-Gvili

Marianne D van de Wetering

1

0 references

4

object named as

Marianne D van de Wetering

0 references

Leontien C Kremer

5

object named as

Leontien CM Kremer

0 references

Abigail Fraser

Cochrane Database of Systematic Reviews

2

object named as

Abigail Fraser

0 references

publication date

19 October 2005

0 references

published in

0 references

cites work

Pefloxacin and vancomycin vs. gentamicin, colistin sulphate and vancomycin for prevention of infections in granulocytopenic patients: a randomised double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Role of Vancomycin as a Component of Oral Nonabsorbable Antibiotics for Microbial Suppression in Leukemic Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Comparison of norfloxacin with cotrimoxazole for infection prophylaxis in acute leukemia. The trade-off for reduced gram-negative sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Chemoprophylaxis with ciprofloxacin in ovarian cancer patients receiving paclitaxel: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Trimethoprim/sulfamethoxazole versus placebo: a double-blind comparison of infection prophylaxis in patients with small cell carcinoma of the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Co-trimoxazole for prevention of infection in acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin vs ciprofloxacin plus amoxicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylaxis of bacterial infections after bone marrow transplantation. A randomized prospective study comparing oral broad-spectrum nonabsorbable antibiotics (vancomycin-tobramycin-colistin) to absorbable antibiotics (ofloxacin-amoxicillin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Rifampin does not improve the efficacy of quinolone antibacterial prophylaxis in neutropenic cancer patients: results of a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Selective suppression of alimentary tract microbial flora as prophylaxis during granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Oral trimethoprim/sulfamethoxazole in attempt to prevent infection after induction chemotherapy for acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylaxis of fever and infection in adult cancer patients. A placebo-controlled trial of oral trimethoprim-sulfamethoxazole plus erythromycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of infection in acute leukemia: a prospective randomized study on the efficacy of two different drug regimens for antimicrobial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: a prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Laminar air flow isolation and decontamination: a prospective randomized study of the effects of prophylactic systemic antibiotics in bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of gram-positive infections in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with acute leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veterans Affairs Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylactic trimethoprim-sulfamethoxazole during consolidation chemotherapy for acute leukemia: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Infections in neutropenic patients. II: Management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Sequential prophylactic oral and empiric once-daily parenteral antibiotics for neutropenia and fever after high-dose chemotherapy and autologous bone marrow support

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

The influence of antimicrobial prophylaxis on the microbial and clinical findings in patients after autologous bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Empiric use of vancomycin during prolonged treatment-induced granulocytopenia. Randomized, double-blind, placebo-controlled clinical trial in patients with acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Infections in neutropenic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of infection in the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylaxis, cost and effectiveness of therapy of infections caused by Gram-positive organisms in neutropenic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Infections caused by viridans streptococci in patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Concentration of pefloxacin in feces during infection prophylaxis in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Treatment of febrile neutropenia: what is new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Changing epidemiology of infections in patients with neutropenia and cancer: emphasis on gram-positive and resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Antibacterial prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Systematic Reviews in Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Analysis of antimicrobial resistance among gram-negative bacilli and antimicrobial use in intensive care unit patients for 5 years in a Veterans Affairs medical center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Successful Chemoprophylaxis forPneumocystis cariniiPneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

The prophylaxis of bacterial infections in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Patterns of multiple resistance to antibiotics in gram-negative bacteria demonstrated by factor analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Prevention of infections in the neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

Randomized controlled trial comparing trimethoprim/sulfamethoxazole and trimethoprim for infection prophylaxis in hospitalized granulocytopenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Effect of trimethoprim/sulfamethoxazole prophylaxis on outcome of childhood lymphocytic leukemia. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

The antiviral prophylaxis of post-transplant lymphoproliferative disorder

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Antimicrobial prophylaxis in acute leukaemia: prospective randomized study comparing two methods of selective decontamination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

E.O.R.T.C. Gnotobiotic Project Group: a prospective cooperative study of antimicrobial decontamination in granulocytopenic patients. Comparison of two different methods

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Ciprofloxacin and norfloxacin for selective decontamination in patients with severe granulocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

[Comparative study on the value of selective decontamination of the digestive tract in acute leukemia patients (author's transl)]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Norfloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Norfloxacin for prevention of bacterial infections in granulocytopenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Gram-positive bacteraemia in granulocytopenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Planned progressive antimicrobial therapy in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

A comparison of trimethoprim-sulfamethoxazole plus nystatin with gentamicin plus nystatin in the prevention of infections in acute leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Failure of oral trimethoprim-sulfamethoxazole prophylaxis in acute leukemia: isolation of resistant plasmids from strains of Enterobacteriaceae causing bacteremia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Urinary tract infection caused by Kluyvera ascorbata in an immunocompromised patient: case report and review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Reply to the article "Editorial comments on 'reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'",

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prevention of infection in the neutropenic patient

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Selective antimicrobial modulation as prophylaxis against infection during granulocytopenia: trimethoprim-sulfamethoxazole vs. nalidixic acid

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Cotrimoxazole Prophylaxis in Patients With Leukemia and Prolonged Granulocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prevention of infection in neutropenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Use of fluoroquinolones as prophylactic agents in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prophylaxis of bacterial infections with ciprofloxacin in patients undergoing bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Oral antimicrobial prophylaxis in bone marrow transplant recipients: randomized trial of ciprofloxacin versus ciprofloxacin-vancomycin.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Co-trimoxazole prophylaxis during high-dose chemotherapy of small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Antimicrobial prophylaxis in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prophylactic Use of Ofloxacin in Granulocytopenic Patients with Hematological Malignancies during Post-remission Chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prevention of bacterial and fungal infections in acute leukemia patients: a new and potent combination of oral norfloxacin and amphotericin B.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Prophylactic levofloxacin to prevent infections in newly diagnosed symptomatic myeloma: the TEAMM RCT

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

Infection prevention in acute nonlymphocytic leukemia. Laminar air flow room reverse isolation with oral, nonabsorbable antibiotic prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386.PUB2

7 January 2021

10.1002/14651858.CD004386.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3504375

OpenCitations bibliographic resource ID

3504375

1 reference